ISPE Biologics Development Symposium 2015 will be held in Lanzhou from Octo22-24. Applitech will set a booth in this symposium.
The global biopharmaceutical industry continues to expand at rapid rate in recent years,which has created unprecedented development opportunities for the pharmaceutical andmedical industries in China. CFDA rolled out its own biosimilar guideline this March, which inturn created unprecedented opportunities in China. The support of policy and regulatory will accelerate the growth of the biopharmaceutical industry in China.
This symposium will devote 1.5 days to discuss:
● Interactive forum devoted to discuss with expert for the regulatory issues of biosimilar and innovative drugs
● CMC on Manufacturing and Innovative of Biologics
● Clinical and regulatory considerations and case studies for biosimilar development
Learning Objectives
● Meet with key CFDA officers and regulators to learn the current status of biosimilar and innovative biologics guideline development in China
● Learn from world class experts the current biologics development technologies, quality standards and practices in novel biologics development such as ADC and biospecific antibodies
● Understand the latest China regulatory guidelines and how they relate to biologics development in China
● Learn the current clinical development strategies and case studies for biosimilar development in China and around the world
● Learn the global new trends, new technologies and new products on Vaccine development
● Communicate with each other about innovation development of China vaccine manufacturing process technology
|
中 文
English
